A long-term follow-up study investigating health-related quality of life and resource use in survivors of severe sepsis: comparison of recombinant human activated protein C with standard care
Christopher J. Longo(McMaster University), Andrew G. Day(Kingston Health Sciences Centre), Daren K. Heyland(Queen's University), Harold Fisher, Claudio M. Martin(Western University), Robert Fowler(Sunnybrook Health Science Centre)
Cited by 30
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study
|Intensive Care Medicine|2001|984
What is an intensive care unit? A report of the task force of the World Federation of Societies of Intensive and Critical Care Medicine
|Journal of Critical Care|2016|841
Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?
|Critical Care Medicine|2001|597